Larvol Delta - Polpharma-Biologics-Group-Announces-that-the-Biologics-License-Application-BLA-Submitted-by-its-Joint-Venture-Bioeq-for-its-Biosimilar-Ranibizumab-has-Been-Accepted-for-Review-by-the-US-Food-and-Drug-Administration-FDA

FYB201 (ranibizumab biosimilar) - Amneal, Formycon, Coherus Biosci, Teva

https://finance.yahoo.com/news/polpharma-biologics-group-announces-biologics-093100260.html

Oct 4, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next